Table II.
Correlation between the assessed miRNAs and clinical parameters in patients with PDAC and CP.
| A, PDAC | |||
|---|---|---|---|
| Clinical parameter | Relative expression of the miRNA | r | P-value |
| C-reactive protein | miR-10b-5p | 0.429 | 0.047a |
| Alkaline phosphatase | miR-210-3p | 0.605 | 0.022a |
| γ-glutamyltranspeptidase | miR-210-3p | 0.529 | 0.029a |
| B, CP | |||
| Clinical parameter | Relative expression of the miRNA | r | P-value |
| Carbohydrate antigen 19-9 | miR-10b-5p | 0.483 | 0.005b |
aP<0.05,
bP<0.01. CP, chronic pancreatitis; PDAC, pancreatic ductal adenocarcinoma; miR/miRNA, microRNA.